Skip to main
MCS

Marcus (MCS) Stock Forecast & Price Target

Marcus (MCS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Marcus is poised to benefit from their strong balance sheet, conservative operating strategy, and a solid performance across both of its business segments including a diverse collection of box office franchises, strong group business demand, and continued renovation. With a slow but steady recovery in the hospitality sector, Marcus is well-positioned to weather potential economic fluctuations and continue to invest in growth opportunities while maintaining its strong financial standing. Overall, Marcus’ strong fundamentals and potential for further growth make it an attractive investment option.

Bears say

Marcus is facing a challenging situation as the COVID-19 pandemic has had a major impact on the movie and hotel industries. With the majority of their revenue coming from the movie theatre segment, the continued uncertainty and potential for restrictions in the near future will likely have a negative effect on their financials and stock performance. Additionally, even though the hotel segment may see some demand, it may not be enough to offset the losses from the movie theatres, making a full recovery for the company uncertain.

Marcus (MCS) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Marcus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Marcus (MCS) Forecast

Analysts have given Marcus (MCS) a Buy based on their latest research and market trends.

According to 4 analysts, Marcus (MCS) has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Marcus (MCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.